Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Start for Free
/Free Sign Up
 0
🧠 Watchlist Wednesday: Copy Legendary Investors' Portfolios in One Click COPY FOR FREE
Close

Croda International PLC (CRDA)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
3,891.0 +11.0    +0.28%
- Real-time Data. Currency in GBP ( Disclaimer )
  • Volume: 48,548
  • Bid/Ask: 3,898.0 / 3,902.0
  • Day's Range: 3,871.0 - 3,927.5
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BJFFLV09 
SEDOL:  BJFFLV0
Croda Intl 3,891.0 +11.0 +0.28%

CRDA Balance Sheet

 
Assess the latest Croda balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced CRDA Annual Report data, financial summaries and charts are available for Croda International PLC investors with their own InvestingPro account.
AnnualQuarterly
Advanced Balance Sheet
Collapse All
Period Ending: 2024
30/06
 2024
31/03
 2023
31/12
 2023
30/09
Total Current Assets 920.6 920.6 909.4 909.4
Cash and Short Term Investments 209.3 209.3 172.5 172.5
Cash - - - -
Cash & Equivalents 209.3 209.3 172.5 172.5
Short Term Investments - - - -
Total Receivables, Net 353.9 353.9 383.8 383.8
Accounts Receivables - Trade, Net 353.9 353.9 318 318
Total Inventory 357.4 357.4 341.2 341.2
Prepaid Expenses - - 11.9 11.9
Other Current Assets, Total - - - -
Total Assets 3579.4 3579.4 3579.2 3579.2
Property/Plant/Equipment, Total - Net 1131 1131 1131.5 1131.5
Property/Plant/Equipment, Total - Gross - - 1675.1 1675.1
Accumulated Depreciation, Total - - -543.6 -543.6
Goodwill, Net - - 937.9 937.9
Intangibles, Net 1357 1357 1408.5 1408.5
Long Term Investments 1.9 1.9 1.9 1.9
Note Receivable - Long Term - - 65.8 65.8
Other Long Term Assets, Total 151.7 151.7 113.5 113.5
Other Assets, Total 20.7 20.7 -966.1 -966.1
Total Current Liabilities 338 338 320.2 320.2
Accounts Payable 267.1 267.1 125.8 125.8
Payable/Accrued - - - -
Accrued Expenses - - 80.9 80.9
Notes Payable/Short Term Debt 19.6 19.6 22.3 22.3
Current Port. of LT Debt/Capital Leases 24.6 24.6 28.1 28.1
Other Current liabilities, Total 26.7 26.7 63.1 63.1
Total Liabilities 1243.6 1243.6 1211.1 1211.1
Total Long Term Debt 673 673 659.7 659.7
Long Term Debt 604.3 604.3 588.4 588.4
Capital Lease Obligations 68.7 68.7 71.3 71.3
Deferred Income Tax 196.1 196.1 192.8 192.8
Minority Interest 14.6 14.6 15.6 15.6
Other Liabilities, Total 2.3 2.3 -19.5 0.5
Total Equity 2335.8 2335.8 2368.1 2368.1
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 15.1 15.1 15.1 15.1
Additional Paid-In Capital 707.7 707.7 707.7 707.7
Retained Earnings (Accumulated Deficit) 1661.3 1661.3 1640 1640
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total -48.3 -48.3 5.3 5.3
Total Liabilities & Shareholders' Equity 3579.4 3579.4 3579.2 3579.2
Total Common Shares Outstanding 139.51 139.51 139.58 139.58
Total Preferred Shares Outstanding - - - -
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

CRDA Price Commentary

Write your thoughts about Croda International PLC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Al Al
Al Al Jun 09, 2023 11:07
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
De-Stocking hurting share price. Expect it to rise again next month. £52.36
Reply
0 0
Report
Mo Ahmadi
Mo Ahmadi Jan 13, 2022 16:08
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
falling knifive!!why?
Reply
1 0
Report
Al Al
Al Al Jul 27, 2021 12:14
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
+6% today. Great company with a strong future.
Reply
3 0
Report
Mike Liv
R2D2 Apr 02, 2021 22:46
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Excellent article in Shares Magazine ,01/04/2021, about Croda this week, worth a read. Pfizer contract a new revenue stream plus MRNA vaccines related work . chemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.Investors should buychemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.chemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.Investors should buychemicals firm Croda - ahighly exciting stock whichshould provide substantialmulti-year returns for investors.What’s firing our excitementis the new-found expertise inits healthcare division in socalledlipid nanoparticles orLNPs, which are fatty moleculesused in drugs and vaccines toencase and protect the stuff inthe drugs and vaccines that helppeople.
Reply
1 0
Report
Rofik Ali
Rofik Ali May 13, 2020 3:06
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
very expensive
Reply
3 2
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Apple
Continue with Google
or
Sign up with Email